Search

Search Constraints

You searched for: Author/Creator Ott, Brian R

Search Results

3. Anticholinergic/Sedative Drug Burden and Subjective Cognitive Decline in Older Adults at Risk of Alzheimer's Disease. (4th September 2020)

4. Association of APOE genotype and lipid lowering with cognitive function in a randomized placebo‐controlled trial of Evolocumab: Developing topics. (7th December 2020)

6. Blood‐brain barrier dysfunction and perioperative neurocognitive disorders: Cognitive Recovery after Elective Surgery (CREATES) study design and methods: Biomarkers (non‐neuroimaging) / Novel biomarkers. (7th December 2020)

7. Clinical efficacy and safety of achieving very low LDL-cholesterol concentrations with the PCSK9 inhibitor evolocumab: a prespecified secondary analysis of the FOURIER trial. Issue 10106 (28th October 2017)

8. Implementation of a targeted screening program for Alzheimer's disease risk in a primary care setting: Dementia care research (research projects; nonpharmacological) / Assessment and care planning. (7th December 2020)

9. Neuroticism moderates the association between beliefs about medications and reported adverse medication effects in mild cognitive impairment. (1st February 2022)

10. Neuroticism moderates the association between beliefs about medications and reported adverse medication effects in mild cognitive impairment. (December 2021)